Vivanta Industries Signs Collaboration Agreement with Qness Pharmaceuticals for Pharmaceutical Product Manufacturing and Supply
Vivanta Industries Limited has entered into a business collaboration agreement with Qness Pharmaceuticals, a proprietorship concern, concerning the manufacture, supply, branding, and marketing of pharmaceutical and allied products. The collaboration is domestic in scope and is set to strengthen Vivanta's presence in the pharmaceutical sector.The agreements outline a framework for collaboration covering the entire product lifecycle, from manufacturing and procurement to branding, supply, and distribution activities.
Key details regarding this strategic arrangement are summarized below:
| Particulars | Details |
|---|---|
| Entity Signed With | Qness Pharmaceuticals (Proprietorship Concern) |
| Area of Agreement | Collaboration for manufacture, procurement, supply, branding, marketing and distribution of pharmaceutical and allied products. |
| Scope of Operation | The parties shall collaborate for manufacture and/or procurement of pharmaceutical products and undertake branding, supply and distribution activities in accordance with the terms of the respective agreements and mutually agreed commercial arrangements. |
| Consideration Details | No upfront consideration has been paid or received. Commercial consideration will be determined based on individual purchase orders and mutually agreed commercial terms from time to time. |
Significant Terms and Strategic Rationale
The collaboration agreements are designed to provide a structured framework for manufacturing, procuring, supplying, branding, and distributing pharmaceutical products. A crucial element of the agreement is that ownership of intellectual property shall remain with the respective owner. Product-wise pricing and operational terms will be managed through mutually agreed purchase orders, and the arrangements do not result in any transfer of management or control of Vivanta Industries Limited.The parties confirmed that the arrangement does not fall under related party transactions. Qness Pharmaceuticals is noted as a proprietorship concern engaged in the business of pharmaceutical products, and the transactions are intended to be undertaken on an arm's length basis.
Vivanta Industries expects these agreements to expand its product portfolio and enhance market reach within the pharmaceutical sector through contract manufacturing and supply arrangements. The expected benefits include creating opportunities for overall business growth.
Stock Price Movement
Vivanta Industries Ltd shares are edging higher at ₹1.80, ticking up 1.69% as of 13:47. The equity has traded within a confined intraday range, moving between lows recorded at ₹1.76 and highs reaching ₹1.82.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.